Pot Stock Analyst Downgrade Brings $400 Million Hit to Aurora Cannabis

By in Wiet, Zakelijk on 19 juli 2019

Whether it be medical marijuana or recreational marijuana, there is expected to nearly limitless growth in he United States for the successful businesses that get their models right.
That said, it’s not unusual for an emerging sector to from a fad-trade to a bubble — only to see that bubble deflate, even if the trend for the industry ahead is looking at exponential growth. Aurora Cannabis Inc. (NYSE: ACB) had already come down hard from its high in 2019.

Ga naar Bron